We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Alphabet (Google) Class C
GOOG
$3.87T
| $138M | 2.47% |
3,560,120
+373,160
| +12% | +$14.2M |
|
|
2
Apple
AAPL
$4.72T
| $113M | 2.02% |
4,001,956
-857,980
| -18% | -$22.7M |
|
3
Amazon
AMZN
$2.5T
| $92.4M | 1.65% |
2,207,600
+492,060
| +29% | +$18.8M |
|
4
Microsoft
MSFT
$2.82T
| $66.9M | 1.2% |
1,161,536
+11,400
| +1% | +$643K |
|
5
Amgen
AMGN
$199B
| $57M | 1.02% |
341,554
+17,391
| +5% | +$2.94M |
|
6
Johnson & Johnson
JNJ
$621B
| $56.8M | 1.01% |
480,460
+75,390
| +19% | +$9.15M |
|
7
Mastercard
MA
$465B
| $55.4M | 0.99% |
544,156
+103,840
| +24% | +$9.96M |
|
8
Gilead Sciences
GILD
$162B
| $53.5M | 0.96% |
676,204
+157,850
| +30% | +$12.8M |
|
9
AT&T
T
$159B
| $53M | 0.95% |
1,729,223
+239,127
| +16% | +$7.56M |
|
10
PepsiCo
PEP
$184B
| $50.5M | 0.9% |
464,742
+17,990
| +4% | +$1.94M |
|
|
11
Bristol-Myers Squibb
BMY
$126B
| $49.4M | 0.88% |
+916,932
| New | +$58.9M |
|
12
Wells Fargo
WFC
$261B
| $47M | 0.84% |
1,060,983
+202,110
| +24% | +$9.67M |
|
|
ARRS
13
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $42.9M | 0.77% |
1,512,843
+114,210
| +8% | +$3.05M |
|
|
14
EOG Resources
EOG
$78.3B
| $41.5M | 0.74% |
+429,006
| New | +$37.7M |
|
15
Biogen
BIIB
$30B
| $40.4M | 0.72% |
129,093
+34,620
| +37% | +$10.3M |
|
16
Cardinal Health
CAH
$52.6B
| $40.1M | 0.72% |
515,684
+92,760
| +22% | +$7.5M |
|
17
Northrop Grumman
NOC
$77.1B
| $40M | 0.71% |
186,898
+78,390
| +72% | +$17M |
|
|
VMW
18
DELISTED
VMware, Inc
VMW
| $39.8M | 0.71% |
542,758
+78,900
| +17% | +$5.55M |
|
19
Nike
NKE
$61.1B
| $39.1M | 0.7% |
743,410
+65,000
| +10% | +$3.67M |
|
20
Citigroup
C
$221B
| $38.9M | 0.69% |
822,740
+203,270
| +33% | +$9.25M |
|
21
Western Digital
WDC
$192B
| $37.5M | 0.67% |
848,559
+156,683
| +23% | +$5.9M |
|
22
Citizens Financial Group
CFG
$30B
| $37.1M | 0.66% |
1,501,658
+202,260
| +16% | +$4.65M |
|
23
Elevance Health
ELV
$82.7B
| $36.5M | 0.65% |
290,919
+51,902
| +22% | +$6.7M |
|
24
McKesson
MCK
$96B
| $36.1M | 0.64% |
216,220
+34,627
| +19% | +$6.45M |
|
25
Verizon
VZ
$186B
| $35.9M | 0.64% |
691,348
+222,850
| +48% | +$12M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.